HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
The drug sensitivities of human immunodeficiency virus (HIV) isolates from a group of patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) who were receiving zidovudine (3′-azido-3′-deoythymidine, AZT) therapy were tested by means of a newly developed plaque assay in CD4 + HeLa cells. Fifty percent inhibitory dose (ID 50 ) values of 18 isolates from untreated individuals ranged between 0.01 μ M and 0.05 μ M . In contrast, most isolates from patients who had received zidovudine for 6 months or more exhibited decreased sensitivity characterized by changes in ID 50 or ID 95 values (or both), with isolates from several patients (5/15) showing 100-fold increases in ID 50 . The latter isolates were also insensitive to 3′-azido-2′,3′-dideoxyuridine; however, the isolates were still sensitive to 2′,3′-dideoxycytidine, 2′,3′-dideoxy-2′,3′-didehydrothymidine, or phosphonoformate. It cannot be determined from this small sample of patients whether development of a less sensitive virus phenotype results in clinical resistance. Appearance of such variants was not associated with a consistent increase in viral p24 concentrations in patient plasma and did not herald any sudden deterioration in clinical status. More extensive studies are required to determine the clinical significance. Thus, it would be premature to alter any treatment protocols for HIV-infected individuals at present.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a clinical trial, its dramatic short-term effects in delaying the death of AIDS patients (109) led to its rapid approval for use, although the virus rebounded after a few months due to the appearance of mutations in RT that render it AZT resistant (110).”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [110]
Citations
Cites
The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
Fischl, M. A., Richman, D. D., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Schooley, R. T., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707233170401 · Cited by 2,995
Self-citationThe Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
Richman, D. D., Fischl, M. A., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Hirsch, M. S., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707233170402 · Cited by 1,199
Self-citationInfection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque Assay
Harada, S., Koyanagi, Y., & Yamamoto, N. (1985) · Science · doi:10.1126/science.2992081 · Cited by 857
Schmitt, F. A., Bigley, J. W., McKinnis, R., Logue, P. E., Evans, R. W., Drucker, J. L., & The AZT Collaborative Working Group* (1988) · New England Journal of Medicine · doi:10.1056/nejm198812153192404 · Cited by 396
Klecker, R. W., Collins, J. M., Yarchoan, R., Thomas, R., Jenkins, J. F., Broder, S., & Myers, C. E. (1987) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1987.49 · Cited by 381
Site-specific mutagenesis of AIDS virus reverse transcriptase
Larder, B. A., Purifoy, D. J. M., Powell, K. L., & Darby, G. (1987) · Nature · doi:10.1038/327716a0 · Cited by 312
Self-citationDevelopment of a sensitive quantitative focal assay for human immunodeficiency virus infectivity
Chesebro, B., & Wehrly, K. (1988) · Journal of Virology · doi:10.1128/jvi.62.10.3779-3788.1988 · Cited by 304
Field, H. J., & Darby, G. (1980) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.17.2.209 · Cited by 242
Self-citationISOLATION AND CHARACTERISATION OF RESISTANT HERPES SIMPLEX VIRUS AFTER ACYCLOVIR THERAPY
Burns, W., Santos, G., Saral, R., Laskin, O., Lietman, P., Mclaren, C., & Barry, D. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91620-8 · Cited by 240
Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance
Darby, G., Field, H. J., & Salisbury, S. A. (1981) · Nature · doi:10.1038/289081a0 · Cited by 204
Self-citation
Cited by
Huang, H., Chopra, R., Verdine, G. L., & Harrison, S. C. (1998) · Science · doi:10.1126/science.282.5394.1669 · Cited by 1,420
Volberding, P. A., Lagakos, S. W., Koch, M. A., Pettinelli, C., Myers, M. W., Booth, D. K., Balfour, H. H., Reichman, R. C., Bartlett, J. A., Hirsch, M. S., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004053221401 · Cited by 1,283
Self-citationMultiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)
Larder, B. A., & Kemp, S. D. (1989) · Science · doi:10.1126/science.2479983 · Cited by 1,163
Self-citationDynamics of HIV infection of CD4+ T cells
Perelson, A. S., Kirschner, D. E., & De Boer, R. (1993) · Mathematical Biosciences · doi:10.1016/0025-5564(93)90043-a · Cited by 976
Rational Design of Peptide-Based HIV Proteinase Inhibitors
Roberts, N. A., Martin, J. A., Kinchington, D., Broadhurst, A. V., Craig, J. C., Duncan, I. B., Galpin, S. A., Handa, B. K., Kay, J., Kröhn, A., et al. (1990) · Science · doi:10.1126/science.2183354 · Cited by 929
Pathogenesis of human immunodeficiency virus infection
Levy, J. A. (1993) · Microbiological Reviews · doi:10.1128/mr.57.1.183-289.1993 · Cited by 839
Hirsch, M. S., Brun-Vézinet, F., D'Aquila, R. T., Hammer, S. M., Johnson, V. A., Kuritzkes, D. R., Loveday, C., Mellors, J. W., Clotet, B., Conway, B., et al. (2000) · JAMA · doi:10.1001/jama.283.18.2417 · Cited by 766
Self-citationDeeley, R. G., Westlake, C., & Cole, S. P. C. (2006) · Physiological Reviews · doi:10.1152/physrev.00035.2005 · Cited by 761
The Dawn of Darwinian Medicine
Williams, G. C., & Nesse, R. M. (1991) · The Quarterly Review of Biology · doi:10.1086/417048 · Cited by 745
Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine
Collier, A. C., Coombs, R. W., Schoenfeld, D. A., Bassett, R. L., Timpone, J., Baruch, A., Jones, M., Facey, K., Whitacre, C., McAuliffe, V. J., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604183341602 · Cited by 745
Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor
Merluzzi, V. J., Hargrave, K. D., Labadia, M., Grozinger, K., Skoog, M., Wu, J. C., Shih, C.-K., Eckner, K., Hattox, S., Adams, J., et al. (1990) · Science · doi:10.1126/science.1701568 · Cited by 743
Molecular Targets for AIDS Therapy
Mitsuya, H., Yarchoan, R., & Broder, S. (1990) · Science · doi:10.1126/science.1699273 · Cited by 732
STRUCTURES OF TERNARY COMPLEXES OF RAT DNA POLYMERASE BETA, A DNA TEMPLATE-PRIMER, AND DDCTP: 2bpf
Pelletier, H., Sawaya, M. R., Kumar, A., Wilson, S. H., & Kraut, J. (1994) · Worldwide Protein Data Bank · doi:10.2210/pdb2bpf/pdb · Cited by 692
Resistance to ddI and Sensitivity to AZT Induced by a Mutation in HIV-1 Reverse Transcriptase
St. Clair, M. H., Martin, J. L., Tudor-Williams, G., Bach, M. C., Vavro, C. L., King, D. M., Kellam, P., Kemp, S. D., & Larder, B. A. (1991) · Science · doi:10.1126/science.1716788 · Cited by 679
Self-citationVirus dynamics and drug therapy
Bonhoeffer, S., May, R. M., Shaw, G. M., & Nowak, M. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6971 · Cited by 632
Potential Mechanism for Sustained Antiretroviral Efficacy of AZT-3TC Combination Therapy
Larder, B. A., Kemp, S. D., & Harrigan, P. R. (1995) · Science · doi:10.1126/science.7542804 · Cited by 623
Self-citationTisdale, M., Kemp, S. D., Parry, N. R., & Larder, B. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5653 · Cited by 603
Self-citationStructures of Ternary Complexes of Rat DNA Polymerase β, a DNA Template-Primer, and ddCTP
Pelletier, H., Sawaya, M. R., Kumar, A., Wilson, S. H., & Kraut, J. (1994) · Science · doi:10.1126/science.7516580 · Cited by 598
Hirsch, M. S., Günthard, H. F., Schapiro, J. M., Brun‐Vézinet, F., Clotet, B., Hammer, S. M., Johnson, V. A., Kuritzkes, D. R., Mellors, J. W., Pillay, D., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/589297 · Cited by 573
Self-citationHirsch, M. S., Conway, B., D'Aquila, R. T., Johnson, V. A., Brun-Vézinet, F., Clotet, B., Demeter, L. M., Hammer, S. M., Jacobsen, D. M., Kuritzkes, D. R., et al. (1998) · JAMA · doi:10.1001/jama.279.24.1984 · Cited by 563
Self-citationKempf, D. J., Marsh, K. C., Denissen, J. F., McDonald, E., Vasavanonda, S., Flentge, C. A., Green, B. E., Fino, L., Park, C. H., & Kong, X. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2484 · Cited by 560
Eron, J. J., Benoit, S. L., Jemsek, J., MacArthur, R. D., Santana, J., Quinn, J. B., Kuritzkes, D. R., Fallon, M. A., & Rubin, M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512213332502 · Cited by 531
Sulfated Polysaccharides Extracted from Sea Algae as Potential Antiviral Drugs
Witvrouw, M., & De Clercq, E. (1997) · General Pharmacology: The Vascular System · doi:10.1016/s0306-3623(96)00563-0 · Cited by 530
L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor.
Vacca, J. P., Dorsey, B. D., Schleif, W. A., Levin, R. B., McDaniel, S. L., Darke, P. L., Zugay, J., Quintero, J. C., Blahy, O. M., & Roth, E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4096 · Cited by 527
Mechanism of Inhibition of HIV-1 Reverse Transcriptase by Nonnucleoside Inhibitors
Spence, R. A., Kati, W. M., Anderson, K. S., & Johnson, K. A. (1995) · Science · doi:10.1126/science.7532321 · Cited by 522
Hirsch, M. S., Brun‐Vezinet, F., Clotet, B., Conway, B., Kuritzkes, D. R., D’Aquila, R. T., Demeter, L. M., Hammer, S. M., Johnson, V. A., Loveday, C., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/375597 · Cited by 514
Self-citationDarbyshire, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)05387-1 · Cited by 509
Schuurman, R., Nijhuis, M., van Leeuwen, R., Schipper, P., de Jong, D., Collis, P., Danner, S. A., Mulder, J., Loveday, C., Christopherson, C., et al. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1411 · Cited by 503
Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance
Wainberg, M. A. (1998) · JAMA · doi:10.1001/jama.279.24.1977 · Cited by 498
Molecular Epidemiology of HIV Transmission in a Dental Practice
Ou, C.-Y., Ciesielski, C. A., Myers, G., Bandea, C. I., Luo, C.-C., Korber, B. T. M., Mullins, J. I., Schochetman, G., Berkelman, R. L., Economou, A. N., et al. (1992) · Science · doi:10.1126/science.256.5060.1165 · Cited by 492
Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption
Bar, K. J., Sneller, M. C., Harrison, L. J., Justement, J. S., Overton, E. T., Petrone, M. E., Salantes, D. B., Seamon, C. A., Scheinfeld, B., Kwan, R. W., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1608243 · Cited by 455
Abortive HIV Infection Mediates CD4 T Cell Depletion and Inflammation in Human Lymphoid Tissue
Doitsh, G., Cavrois, M., Lassen, K. G., Zepeda, O., Yang, Z., Santiago, M. L., Hebbeler, A. M., & Greene, W. C. (2010) · Cell · doi:10.1016/j.cell.2010.11.001 · Cited by 452
Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay.
Herz, A. V., Bonhoeffer, S., Anderson, R. M., May, R. M., & Nowak, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7247 · Cited by 440
In Vivo Activity Against HIV and Favorable Toxicity Profile of 2′,3′-Dideoxyinosine
Yarchoan, R., Mitsuya, H., Thomas, R. V., Pluda, J. M., Hartman, N. R., Perno, C.-F., Marczyk, K. S., Allain, J.-P., Johns, D. G., & Broder, S. (1989) · Science · doi:10.1126/science.2502840 · Cited by 427
Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1.
Terai, C., Kornbluth, R. S., Pauza, C. D., Richman, D. D., & Carson, D. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115188 · Cited by 421
Self-citationRNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase.
Tuerk, C., MacDougal, S., & Gold, L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6988 · Cited by 415
Kellam, P., Boucher, C. A., & Larder, B. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1934 · Cited by 413
Self-citationThe prevalence of antiretroviral drug resistance in the United States
Richman, D. D., Morton, S. C., Wrin, T., Hellmann, N., Berry, S., Shapiro, M. F., & Bozzette, S. A. (2004) · AIDS · doi:10.1097/01.aids.0000131310.52526.c7 · Cited by 408
Self-citationRichman, D., Shih, C. K., Lowy, I., Rose, J., Prodanovich, P., Goff, S., & Griffin, J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11241 · Cited by 393
Self-citationLambert, J. S., Seidlin, M., Reichman, R. C., Plank, C. S., Laverty, M., Morse, G. D., Knupp, C., McLaren, C., Pettinelli, C., Valentine, F. T., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005103221901 · Cited by 390
Hertogs, K., de Béthune, M.-P., Miller, V., Ivens, T., Schel, P., Van Cauwenberge, A., Van den Eynde, C., van Gerwen, V., Azijn, H., van Houtte, M., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.269 · Cited by 389
Self-citationNew developments in the enantioselective synthesis of cyclopentyl carbocyclic nucleosides
Crimmins, M. T. (1998) · Tetrahedron · doi:10.1016/s0040-4020(98)00320-2 · Cited by 388
Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus Infection
Drew, W., Miner, R. C., Busch, D. F., Follansbee, S., Gullett, J., Mehalko, S., Gordon, S. M., Owen, W. F., Matthews, T. R., Buhles, W. C., et al. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/163.4.716 · Cited by 373
Target Cell Limited and Immune Control Models of HIV Infection: A Comparison
De Boer, R. J., & Perelson, A. S. (1998) · Journal of Theoretical Biology · doi:10.1006/jtbi.1997.0548 · Cited by 371
Update of the drug resistance mutations in HIV-1: 2007.
Johnson, V. A., Brun‐Vézinet, F., Clotet, B., Günthard, H. F., Kuritzkes, D. R., Pillay, D., Schapiro, J., & Richman, D. D. (2007) · PubMed · Cited by 368
Self-citationNunberg, J. H., Schleif, W. A., Boots, E. J., O'Brien, J. A., Quintero, J. C., Hoffman, J. M., Emini, E. A., & Goldman, M. E. (1991) · Journal of Virology · doi:10.1128/jvi.65.9.4887-4892.1991 · Cited by 363
Cyclopropane Derivatives and their Diverse Biological Activities
Salaün, J. (2000) · Topics in Current Chemistry · doi:10.1007/3-540-48255-5_1 · Cited by 361
Clinical Pharmacology of 3'-Azido-2',3'-Dideoxythymidine (Zidovudine) and Related Dideoxynucleosides
Oates, J. A., Wood, A. J. J., Yarchoan, R., Mitsuya, H., Myers, C. E., & Broder, S. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909143211106 · Cited by 353
Boucher, C. A. B., O'Sullivan, E., Mulder, J. W., Ramautarsing, C., Kellam, P., Darby, G., Lange, J. M. A., Goudsmit, J., & Larder, B. A. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/165.1.105 · Cited by 352
Self-citationMeyer, P. R., Matsuura, S. E., Mian, A. M., So, A. G., & Scott, W. A. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80185-9 · Cited by 349
Kahn, J. O., Lagakos, S. W., Richman, D. D., Cross, A., Pettinelli, C., Liou, S.-H., Brown, M., Volberding, P. A., Crumpacker, C. S., Beall, G., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208273270901 · Cited by 347
Self-citationHopkins, A. L., Ren, J., Esnouf, R. M., Willcox, B. E., Jones, E. Y., Ross, C., Miyasaka, T., Walker, R. T., Tanaka, H., Stammers, D. K., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960056x · Cited by 346
The HIV-1 Protease as a Therapeutic Target for AIDS
DEBOUCK, C. (1992) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1992.8.153 · Cited by 341
Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes
Vartanian, J. P., Meyerhans, A., Asjö, B., & Wain-Hobson, S. (1991) · Journal of Virology · doi:10.1128/jvi.65.4.1779-1788.1991 · Cited by 341
Targeting the Latent Reservoir for HIV-1
Sengupta, S., & Siliciano, R. F. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.030 · Cited by 340
Clinical utility of HIV-1 genotyping and expert advice: the Havana trial
Tural, C., Ruiz, L., Holtzer, C. D., Schapiro, J., Viciana, P., González, J., Domingo, P., Boucher, C. A., Rey‐Joly, C., & Clotet, B. (2002) · AIDS · doi:10.1097/00002030-200201250-00010 · Cited by 338
Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs
Shen, L., Peterson, S., Sedaghat, A. R., McMahon, M. A., Callender, M., Zhang, H., Zhou, Y., Pitt, E., Anderson, K. S., Acosta, E. P., et al. (2008) · Nature Medicine · doi:10.1038/nm1777 · Cited by 327
Fischl, M. A., Parker, C. B., Pettinelli, C., Wulfsohn, M., Hirsch, M. S., Collier, A. C., Antoniskis, D., Ho, M., Richman, D. D., Fuchs, E., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010113231501 · Cited by 323
Self-citationA Controlled Trial of Zidovudine in Primary Human Immunodeficiency Virus Infection
Kinloch-de Loës, S., Hirschel, B. J., Hoen, B., Cooper, D. A., Tindall, B., Carr, A., Saurat, J.-H., Clumeck, N., Lazzarin, A., Mathiesen, L., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508173330702 · Cited by 307
Gómez-Cano, M., Rubio, A., Puig, T., Pérez-Olmeda, M., Ruiz, L., Soriano, V., Pineda, J. A., Zamora, L., Xaus, N., Clotet, B., et al. (1998) · AIDS · doi:10.1097/00002030-199809000-00008 · Cited by 300
Japour, A. J., Mayers, D. L., Johnson, V. A., Kuritzkes, D. R., Beckett, L. A., Arduino, J. M., Lane, J., Black, R. J., Reichelderfer, P. S., & D'Aquila, R. T. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1095 · Cited by 294
Baba, M., Tanaka, H., De Clercq, E., Pauwels, R., Balzarini, J., Schols, D., Nakashima, H., Perno, C.-F., Walker, R. T., & Miyasaka, T. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92756-3 · Cited by 288
Goldman, M. E., Nunberg, J. H., O'Brien, J. A., Quintero, J. C., Schleif, W. A., Freund, K. F., Gaul, S. L., Saari, W. S., Wai, J. S., & Hoffman, J. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6863 · Cited by 279
Nucleoside Analogues as Chemotherapeutic Agents: A Review
Périgaud, C., Gosselin, G., & Imbach, J. L. (1992) · Nucleosides and Nucleotides · doi:10.1080/07328319208021748 · Cited by 277
Anti-HIV Michellamines from Ancistrocladus korupensis
Boyd, M. R., Hallock, Y. F., Cardellina, J. H., Manfredi, K. P., Blunt, J. W., McMahon, J. B., Buckheit, R. W., Bringmann, G., Schäffer, M., Cragg, G. M. L., et al. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00038a003 · Cited by 274
Porcari, A. R., Devivar, R. V., Kucera, L. S., Drach, J. C., & Townsend, L. B. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970559i · Cited by 272
Reconstruction and Future Trends of the AIDS Epidemic in the United States
Brookmeyer, R. (1991) · Science · doi:10.1126/science.2063206 · Cited by 257
Primary Infection with Zidovudine-Resistant Human Immunodeficiency Virus Type 1
Erice, A., Mayers, D. L., Strike, D. G., Sannerud, K. J., McCutchan, F. E., Henry, K., & Balfour, H. H. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304223281605 · Cited by 256
Barry, M., Gibbons, S., Back, D., & Mulcahy, F. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732030-00003 · Cited by 254
Discovery and development of new antibiotics: the problem of antibiotic resistance
Silver, L. L., & Bostian, K. A. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.377 · Cited by 253
Cooley, T. P., Kunches, L. M., Saunders, C. A., Ritter, J. K., Perkins, C. J., McLaren, C., McCaffrey, R. P., & Liebman, H. A. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005103221902 · Cited by 251
Specific therapy regimes could lead to long-term immunological control of HIV
Wodarz, D., & Nowak, M. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14464 · Cited by 250
Antiviral therapy for human immunodeficiency virus infections
De Clercq, E. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.2.200 · Cited by 246
Iversen, A. K., Shafer, R. W., Wehrly, K., Winters, M. A., Mullins, J. I., Chesebro, B., & Merigan, T. C. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.1086-1090.1996 · Cited by 245
Romero, D. L., Busso, M., Tan, C. K., Reusser, F., Palmer, J. R., Poppe, S. M., Aristoff, P. A., Downey, K. M., So, A. G., & Resnick, L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8806 · Cited by 242
Coates, J. A., Cammack, N., Jenkinson, H. J., Jowett, A. J., Jowett, M. I., Pearson, B. A., Penn, C. R., Rouse, P. L., Viner, K. C., & Cameron, J. M. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.4.733 · Cited by 240
Hu, D. J. (1996) · JAMA · doi:10.1001/jama.275.3.210 · Cited by 240
Soudeyns, H., Yao, X. I., Gao, Q., Belleau, B., Kraus, J. L., Nguyen-Ba, N., Spira, B., & Wainberg, M. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1386 · Cited by 237
Nájera, I., Holguín, A., Quiñones-Mateu, M. E., Muñoz-Fernández, M. A., Nájera, R., López-Galíndez, C., & Domingo, E. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.23-31.1995 · Cited by 237
Moutouh, L., Corbeil, J., & Richman, D. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.6106 · Cited by 235
Self-citationGulick, R. M., Mellors, J. W., Havlir, D., Eron, J. J., Gonzalez, C., McMahon, D., Jonas, L., Meibohm, A., Holder, D., Schleif, W. A., et al. (1998) · JAMA · doi:10.1001/jama.280.1.35 · Cited by 234
Self-citationGao, Q., Gu, Z., Parniak, M. A., Cameron, J., Cammack, N., Boucher, C., & Wainberg, M. A. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.6.1390 · Cited by 228
Gu, Z., Gao, Q., Li, X., Parniak, M. A., & Wainberg, M. A. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.7128-7135.1992 · Cited by 228
Larder, B. A. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.12.2664 · Cited by 228
Self-citationMolecular evidence of HIV-1 transmission in a criminal case
Metzker, M. L., Mindell, D. P., Liu, X.-M., Ptak, R. G., Gibbs, R. A., & Hillis, D. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222522599 · Cited by 226
Markowitz, M., Mo, H., Kempf, D. J., Norbeck, D. W., Bhat, T. N., Erickson, J. W., & Ho, D. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.701-706.1995 · Cited by 226
Emergence of HIV-1 Drug Resistance During Antiretroviral Treatment
Rong, L., Feng, Z., & Perelson, A. S. (2007) · Bulletin of Mathematical Biology · doi:10.1007/s11538-007-9203-3 · Cited by 226
HIV resistance to reverse transcriptase inhibitors
De Clercq, E. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90001-9 · Cited by 225
Inhibition of HIV Replication in Acute and Chronic Infections in Vitro by a Tat Antagonist
Hsu, M.-C., Schutt, A. D., Holly, M., Slice, L. W., Sherman, M. I., Richman, D. D., Potash, M. J., & Volsky, D. J. (1991) · Science · doi:10.1126/science.1763331 · Cited by 223
Self-citationTisdale, M., Alnadaf, T., & Cousens, D. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.1094 · Cited by 223
Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents
Richman, D. D. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.6.1207 · Cited by 223
Self-citationFlavin, M. T., Rizzo, J. D., Khilevich, A., Kucherenko, A., Sheinkman, A. K., Vilaychack, V., Lin, L., Chen, W., Greenwood, E. M., Pengsuparp, T., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950797i · Cited by 219
Richman, D. D. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.03.004 · Cited by 216
Self-citationWinters, M. A., Coolley, K. L., Girard, Y. A., Levee, D. J., Hamdan, H., Shafer, R. W., Katzenstein, D. A., & Merigan, T. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4948 · Cited by 216
Genetic Diversity and Evolution of Retroviruses
Coffin, J. M. (1992) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-77011-1_10 · Cited by 215
2025 update of the drug resistance mutations in HIV-1.
Johnson, V. A., Brun‐Vézinet, F., Clotet, B., Conway, B., Kuritzkes, D. R., Pillay, D., Schapiro, J., Telenti, A., & Richman, D. D. (2005) · PubMed · Cited by 215
Self-citationKrown, S. E., Gold, J. W. M., Niedzwiecki, D., Bundow, D., Flomenberg, N., Gansbacher, B., & Brew, B. J. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-11-812 · Cited by 214
Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection
Hou, P., Chen, S., Wang, S., Yu, X., Chen, Y., Jiang, M., Zhuang, K., Ho, W., Hou, W., Huang, J., et al. (2015) · Scientific Reports · doi:10.1038/srep15577 · Cited by 212
Ho, D. D., Toyoshima, T., Mo, H., Kempf, D. J., Norbeck, D., Chen, C. M., Wideburg, N. E., Burt, S. K., Erickson, J. W., & Singh, M. K. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.2016-2020.1994 · Cited by 212
Gu, Z., Gao, Q., Fang, H., Salomon, H., Parniak, M. A., Goldberg, E., Cameron, J., & Wainberg, M. A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.2.275 · Cited by 211
Metadata
- Authors
- Larder, B. A., Darby, G., & Richman, D. D.
- Affiliations
- Wellcome Trust (GB)
- University of California San Diego (US)
- ORCID
- Richman, Douglas D.
- Venue
- Science
- Published
- 1989-03-31
- Volume
- 243
- Issue
- 4899
- Pages
- 1731-1734
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2086462809
- Cited by
- 1,559
- References
- 22
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 3 · 2023: 10 · 2022: 12 · 2021: 8 · 2020: 9 · 2019: 12 · 2018: 6 · 2017: 13 · 2016: 16 · 2015: 10 · 2014: 21 · 2013: 13 · 2012: 16
- FWCI
- 157.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HB-6-7019)
- National Institute of Allergy and Infectious Diseases (AI-62548, AI-52578)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- HIV drug resistance, zidovudine resistance, AIDS, AIDS-related complex, antiretroviral therapy, 2',3'-dideoxycytidine, phosphonoformate
- MeSH terms
- Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Drug Resistance, HeLa Cells, HIV, Humans, Microbial Sensitivity Tests, Phosphonoacetic Acid, Viral Plaque Assay, Retroviridae Proteins, Virus Replication, Zidovudine, Dideoxynucleosides, Zalcitabine, HIV Core Protein p24, Foscarnet, Reverse Transcriptase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.